Artera Product Webinar – May
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch th [...]
AUA 2024 Prostate Talk
The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. The Arte [...]
How AI Can Help Alleviate the Stress of a...
In an era where cancer rates continue to rise, the emotional toll a cancer diagnosis and the subsequent treatment journey has [...]
MMAI Model Risk Stratification for NCCN Guidelines for Low,...
Zach Klaassen hosts a multidisciplinary roundtable discussing the NCCN Prostate Cancer Guidelines with a focus on the ArteraA [...]
ASTRO 2024 Annual Meeting
Be sure to mark your calendar now to attend the 66th ASTRO Annual Meeting, being held in the nation’s capital, Washington, DC [...]
LUGPA Regional Meeting
LUGPA's regional meetings offer unique, cutting edge content to better navigate the changing healthcare landscape. These inti [...]
ASCO 2024: Randomized PROSTATE-IQ Trial to Reduce ADT Treatment...
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 31st and June 4th, 2024 [...]
Artera Announces Three Presentations at ASCO 2024 That Demonstrate...
Artera, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, will present three [...]